Effects of Aerobic Training in Patients With Ankylosing Spondylitis
1 other identifier
interventional
70
1 country
1
Brief Summary
This is a randomized controlled trial with blinded assessor on the effects of aerobic exercise (walking)in patients with Ankylosing Spondylitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jul 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
April 21, 2012
CompletedFirst Posted
Study publicly available on registry
April 27, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2013
CompletedFebruary 15, 2017
February 1, 2017
1.3 years
April 21, 2012
February 14, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in BASFI
Bath Ankylosing Spondylitis Functional Index (BASFI) is a quaestionnaire with 10 questions about functional capacity validated to AS patients. Each question is answered with a visual analogue scale 0-10 cm. Zero means the best, and 10 the worst function.
Baseline, after 6, 12 and 24 weeks.
Secondary Outcomes (7)
Change in BASDAI
Baseline, after 6, 12 and 24 weeks.
Change in BASMI
Baseline, after 6, 12 and 24 weeks.
Change in HAQ-S
Baseline, after 6, 12 and 24 weeks.
Incremental cardiopulmonary exercise testing protocol by treadmill
Baseline and after 12 weeks.
Levels of C reactive protein and erythrocyte rate sedimentation
Baseline, after 6. 12 and 24 weeks
- +2 more secondary outcomes
Study Arms (2)
Aerobic training
EXPERIMENTALThe patients in this arm perform a 50-minute-walking at anaerobic threshold plus stretching exercises 3 times a week for 12 weeks.
Stretching exercises
PLACEBO COMPARATORThe control group perform global stretching exercises for approximately 20 minutes 3 times a week for 12 weeks.
Interventions
The intervention comprises fifty minutes of walking at anaerobic threshold plus stretching exercises 3 times a week for 12 weeks.
Global stretching exercises will be performed for about 20 minutes 3 times a week for 12 weeks with supervision of specialized physiotherapists.
Eligibility Criteria
You may qualify if:
- Diagnosis of Ankylosing Spondylitis according to New York modified criteria.
- Stable drug treatment for at least 3 months
- Sedentary for at least 3 months before randomization
- Steinbrocker class I/II
You may not qualify if:
- Uncontrolled Systemic Arterial Hypertension and Diabetes mellitus.
- Ischemic heart disease
- Clinically significant diseases
- Orthopedic surgery, such as hip arthroplasty, in the last year.
- Inability to walk.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Federal de Sao Paulo
São Paulo, São Paulo, 04039-002, Brazil
Related Publications (1)
Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, Dagfinrud H, Dijkmans B, Dougados M, Emery P, Geher P, Hammoudeh M, Inman RD, Jongkees M, Khan MA, Kiltz U, Kvien T, Leirisalo-Repo M, Maksymowych WP, Olivieri I, Pavelka K, Sieper J, Stanislawska-Biernat E, Wendling D, Ozgocmen S, van Drogen C, van Royen B, van der Heijde D. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011 Jun;70(6):896-904. doi: 10.1136/ard.2011.151027.
PMID: 21540199BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jamil Natour, Prof, MD
Federal University of São Paulo
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
April 21, 2012
First Posted
April 27, 2012
Study Start
July 1, 2011
Primary Completion
November 1, 2012
Study Completion
February 1, 2013
Last Updated
February 15, 2017
Record last verified: 2017-02